# Gemcitabine/Oxaliplatin and Photodynamic Therapy in Cholangiocarcinoma

> **NCT00713687** · PHASE2 · WITHDRAWN · sponsor: **Technical University of Munich**

## Conditions studied

- Cholangiocarcinoma

## Interventions

- **DRUG:** Gemcitabine, Oxaliplatin, Photodynamic therapy (Photosan®)

## Key facts

- **NCT ID:** NCT00713687
- **Lead sponsor:** Technical University of Munich
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-08
- **Primary completion:** —
- **Final completion:** 2011-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** recruiting failed
- **Last updated:** 2012-08-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00713687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00713687, "Gemcitabine/Oxaliplatin and Photodynamic Therapy in Cholangiocarcinoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00713687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*